BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cui X, Snapper CM. Development of novel vaccines against human cytomegalovirus. Hum Vaccin Immunother 2019;15:2673-83. [PMID: 31017831 DOI: 10.1080/21645515.2019.1593729] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Talavera-barber M, Flint K, Graber B, Dhital R, Kaptsan I, Medoro AK, Sánchez PJ, Shimamura M. Antibody Titers Against Human Cytomegalovirus gM/gN and gB Among Pregnant Women and Their Infants. Front Pediatr 2022;10:846254. [DOI: 10.3389/fped.2022.846254] [Reference Citation Analysis]
2 Shibamura M, Yamada S, Yoshikawa T, Inagaki T, Nguyen PHA, Fujii H, Harada S, Fukushi S, Oka A, Mizuguchi M, Saijo M. Longitudinal trends of neutralizing antibody prevalence against human cytomegalovirus (HCMV) over the past 30 years in Japanese women. Jpn J Infect Dis. [DOI: 10.7883/yoken.jjid.2021.726] [Reference Citation Analysis]
3 Yu M, Jin Y, Zhang S, Xu J, Zhang J. microRNA, a Subtle Indicator of Human Cytomegalovirus against Host Immune Cells. Vaccines 2022;10:144. [DOI: 10.3390/vaccines10020144] [Reference Citation Analysis]
4 Ružić T, Lisnić VJ, Lučin HM, Roviš TL, Železnjak J, Brdovčak MC, Vrbanović A, Oreb D, Kveštak D, Jerčić KG, Borovečki F, Lučin P, Adler B, Jonjić S, Lisnić B. Characterization of M116.1p, a murine cytomegalovirus protein required for efficient infection of mononuclear phagocytes. J Virol 2021;:JVI0087621. [PMID: 34705561 DOI: 10.1128/JVI.00876-21] [Reference Citation Analysis]
5 Cui X, Snapper CM. Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases. Front Immunol 2021;12:734471. [PMID: 34691042 DOI: 10.3389/fimmu.2021.734471] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
6 Zhou R, Liu L, Wang Y. Viral proteins recognized by different TLRs. J Med Virol 2021;93:6116-23. [PMID: 34375002 DOI: 10.1002/jmv.27265] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
7 Choi KY, McGregor A. A Fully Protective Congenital CMV Vaccine Requires Neutralizing Antibodies to Viral Pentamer and gB Glycoprotein Complexes but a pp65 T-Cell Response Is Not Necessary. Viruses 2021;13:1467. [PMID: 34452332 DOI: 10.3390/v13081467] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Cui X, Cao Z, Ishikawa Y, Cui S, Imadome KI, Snapper CM. Immunization with Epstein-Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV Challenge. Vaccines (Basel) 2021;9:285. [PMID: 33808755 DOI: 10.3390/vaccines9030285] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
9 Choi KY, El-Hamdi NS, McGregor A. A trimeric capable gB CMV vaccine provides limited protection against a highly cell associated and epithelial tropic strain of cytomegalovirus in guinea pigs. J Gen Virol 2021;102. [PMID: 33729125 DOI: 10.1099/jgv.0.001579] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Siddiqui S, Hackl S, Ghoddusi H, McIntosh MR, Gomes AC, Ho J, Reeves MB, McLean GR. IgA binds to the AD-2 epitope of glycoprotein B and neutralizes human cytomegalovirus. Immunology 2021;162:314-27. [PMID: 33283275 DOI: 10.1111/imm.13286] [Reference Citation Analysis]
11 Cui X, Cao Z, Wang S, Adler SP, McVoy MA, Snapper CM. Immunization with Human Cytomegalovirus Core Fusion Machinery and Accessory Envelope Proteins Elicit Strong Synergistic Neutralizing Activities. Vaccines (Basel) 2020;8:E179. [PMID: 32294946 DOI: 10.3390/vaccines8020179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Perotti M, Perez L. Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV. Viruses 2019;12:E35. [PMID: 31905677 DOI: 10.3390/v12010035] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
13 Cui X, Cao Z, Wang S, Flora M, Adler SP, McVoy MA, Snapper CM. Immunization of Rabbits with Recombinant Human Cytomegalovirus Trimeric versus Monomeric gH/gL Protein Elicits Markedly Higher Titers of Antibody and Neutralization Activity. Int J Mol Sci 2019;20:E3158. [PMID: 31261659 DOI: 10.3390/ijms20133158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]